This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Menjugate Liquid (2016-03-07)

Starting date:
March 7, 2016
Posting date:
March 17, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-57532

Affected Products

Menjugate Liquid 

Reason

Precautionary measure due to an apparent higher rate of expected adverse reactions.

Depth of distribution

Wholesalers, Provinces, Hospitals

Affected products

Menjugate Liquid

DIN, NPN, DIN-HIM
DIN 02440709
Dosage form

Suspension

Strength
  • Meningococcal Group C Oligosaccharide - 10 mcg/0.5 ml
  • Corynebacterium Diphtheriae CRM-197 Protein - 25 mcg/0.5 ml
Lot or serial number

Lot 150401

Companies
Recalling Firm
GlaxoSmithKline Canada Inc.
7333 Mississauga Rd N
Mississauga
L5N 6L4
Ontario
CANADA
Marketing Authorization Holder
GlaxoSmithKline Canada Inc.
7333 Mississauga Rd N
Mississauga
L5N 6L4
Ontario
CANADA

Date modified: